Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

70 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Active, Not Recruiting

A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.

NCT05683977

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Research Site Angers, France
  • Research Site Argenteuil, France
  • Research Site Avignon, France
  • Research Site Avignon, France
View all 34 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)

NCT04938817

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0152) Gilbert, Arizona, United States
  • Northside Hospital-Northside Hospital Oncology Network ( Site 0156) Atlanta, Georgia, United States
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0180) Fort Wayne, Indiana, United States
  • Baptist Health Lexington-Research ( Site 0158) Lexington, Kentucky, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT06799286

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Local Institution - 0004 Beijing, Beijing Municipality, China
  • Local Institution - 0003 Jinan, Shandong, China
  • Local Institution - 0001 Linyi, Shandong, China
  • Local Institution - 0005 Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax

NCT05617963

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Centre de Radiothérapie du Pays d'Aix Aix-en-Provence, France
  • Centre Hospitalier du Pays d'Aix Aix-en-Provence, France
  • Institut du Cancer Avignon-Provence Avignon, France
  • Centre d'Oncologie du Pays Basque Bayonne, France
View all 32 locations
View Trial Details
Active, Not Recruiting

Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

NCT04665856

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital Beijing, China
  • the First Affiliated Hospital of Bengbu Medical College Bengbu, China
  • the First Hospital of Jilin University Changchun, China
View all 16 locations
View Trial Details
Active, Not Recruiting

Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)

NCT03319940

Conditions
Bites and Stings, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

NCT05224141

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Infirmary Cancer Care ( Site 0022) Mobile, Alabama, United States
  • Los Angeles Hematology Oncology Medical Group ( Site 0006) Los Angeles, California, United States
  • VA West Los Angeles Medical Center ( Site 0004) Los Angeles, California, United States
  • Boca Raton Regional Hospital-Lynn Cancer Institute ( Site 0014) Boca Raton, Florida, United States
View all 140 locations
View Trial Details
Active, Not Recruiting

Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer

NCT02041845

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Rigshospitalet København Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
  • Ålesund sykehus Ålesund, Norway
  • Haukeland Universitetssykehus Bergen, Norway
View all 22 locations
View Trial Details

Related conditions